Q1 2017 Holdings
Filed 2017-05-15 | 72 holdings | $23.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $9.7M | 506,946 | 41.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.5M | 541,128 | 19.5% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $3.0M | 81,231 | 12.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $2.8M | 221,738 | 12.0% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $1.8M | 76,404 | 7.9% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $648.0K | 70,455 | 2.8% |
| Ascendis Pharma(ASND) | SPONSORED ADR | 04351P101 | $510.0K | 18,214 | 2.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $217.0K | 55,700 | 0.9% |
| Loxo Oncology Inc | COM | 548862101 | $12.7K | 300,722 | 0.1% |
| Nxstage Medical Inc | COM | 67072V103 | $5.8K | 216,119 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $4.6K | 221,013 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $3.6K | 867,529 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $3.3K | 82,500 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.0K | 35,359 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $2.8K | 411,000 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $2.7K | 63,484 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM ADDED | 00773J103 | $2.6K | 350,392 | 0.0% |
| Ishares TR Nasdq Biotec(IBB) | ETF | 464287556 | $2.6K | 8,700 | 0.0% |
| Insulet Corp | NOTE 2.000% 6/1 | 45784PAD3 | $2.5K | $2,250,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.5K | 58,508 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $2.2K | 119,200 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.2K | 75,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $2.1K | 46,770 | 0.0% |
| Protalix Biotherapeutics Inc | NOTE 4.500% 9/1 | 74365AAB7 | $2.0K | $2,500,000 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $1.9K | 65,496 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $1.9K | 48,809 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $1.8K | 95,322 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $1.6K | 252,574 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $1.6K | 208,458 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $1.6K | 325,667 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $1.6K | 473,478 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $1.4K | 172,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.4K | 339,614 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.2K | 203,907 | 0.0% |
| Johnson and Johnson(JNJ) | COM | 478160104 | $1.2K | 9,400 | 0.0% |
| Scynexis Inc | COM | 811292101 | $1.1K | 381,900 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $994 | 37,438 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $961 | 1,000,000 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $955 | 28,000 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $944 | 71,320 | 0.0% |
| Syneron Medical LTD | ORD SHS | M87245102 | $907 | 85,947 | 0.0% |
| Tandem Diabetes Care Inc | COM | 875372104 | $869 | 724,286 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $855 | 807,008 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $827 | 196,500 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $821 | 101,317 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $818 | 9,000 | 0.0% |
| Exactech Inc | COM | 30064E109 | $797 | 31,636 | 0.0% |
| Stereotaxis Inc(STXS) | COM | 85916J409 | $782 | 1,372,862 | 0.0% |
| Cascadian Therapeutics Inc | COM NEW | 14740B606 | $767 | 185,259 | 0.0% |
| Novadaq Technologies Inc | COM | 66987G102 | $747 | 95,841 | 0.0% |